regular insulin

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Type 1 DiabetesEffectivenessSpinal Cord InjuryGrowth Hormone Deficiency

79 competitors in Type 1 Diabetes

#DrugCompanyPhaseTrials

1

Ozempic

Novo Nordisk

Phase 3

62

Stelara

Johnson & Johnson

Phase 3

13

Inpefa

LLexicon Pharmaceuticals

Phase 3

54

Tricor

JJagotec

Phase 3

25

Diamox

Teva

Phase 2

26

Kerendia

Bayer

Phase 2

17

Humira

Novartis

Phase 2

18

Teplizumab

Sanofi

Phase 3

99

Prolia

OOrganon and Co

Phase 2

110

Bacillus Calmette-Guérin

Bristol-Myers Squibb

Phase 2

1Show 25 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

14 more indications

Cirrhosis1 trial

Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial

Unknown status·—·Phase 4·NCT01143948·45 enrolled

Stem Cell Transplant1 trial

Glucose Control In Hematopoetic Stem Cell Transplant

Terminated·UUniversity of Oklahoma·N/A·NCT00582036·11 enrolled

Parenteral Nutrition1 trial

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

Completed·KKing Faisal Specialist Hospital & Research Center·Phase 4·NCT02216799·61 enrolled

Effectiveness1 trial

Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis

Completed·TThe University of Texas Health Science Center, Houston·N/A·NCT02006342·40 enrolled

After Cardiac Surgery1 trial

The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.

Unknown status·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·N/A·NCT03324867·316 enrolled

Type 2 Diabetes Mellitus1 trial

Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.

Completed·Sanofi·Phase 4·NCT01122979·72 enrolled

Acute Coronary Syndrome1 trial

Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

Suspended·—·Phase 4·NCT01151176·130 enrolled

Type 2 Diabetes1 trial

Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery

Completed·EEmory University·Phase 4·NCT00596687·234 enrolled

Randomized1 trial

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Completed·XXeris Pharmaceuticals·Phase 2·NCT04074317·18 enrolled

Intensive Care Unit1 trial

Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit

Completed·UUniversity of Roma La Sapienza·Phase 4·NCT02165566·28 enrolled

Stroke1 trial

Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke

Unknown status·NNational Taiwan University Hospital·Phase 3·NCT02607943·120 enrolled

Growth Hormone Deficiency1 trial

Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency

Unknown status·OOregon Health and Science University·N/A·NCT01804413·10 enrolled

Spinal Cord Injury1 trial

Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

Recruiting·HHealthPartners Institute·Phase 1·NCT07384052·12 enrolled

Unspecified2 trials

Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

Completed·BBecton, Dickinson and Company·Phase 2·NCT00553488·30 enrolled

Lyspro Insulin vs Regular Insulin in Cirrhotic Patients

Completed·UUniversity of Campania Luigi Vanvitelli·Phase 4·NCT00513201

Details

Drug Info

Related News